Publications for Emelie Heintz
Co-author map based on ISI articles 2007-

Publications mentioned in social media 16 times*

Keywords

weights utvärdering tto teknologier system st sle retinopathy qaly prioritering patients nya länder läkemedel landsting health dr diabetic diabetes beslut

Journal Articles

Filip K. Arnberg, Steven J. Linton, Monica Hultcrantz, Emelie Heintz and Ulf Jonsson
  Internet-Delivered Psychological Treatments for Mood and Anxiety Disorders: A Systematic Review of Their Efficacy, Safety, and Cost-Effectiveness
 
Altmetric usage: 15

  PLoS ONE, 2014, 9(5), e98118.
   Fulltext  PDF  

Emelie Heintz, Marieke Krol and Lars-Åke Levin
  The impact of patients' subjective life expectancy on time trade-off valuations
  Medical decision making, 2013, 33(2), 261-270.
 Web of Science® Times Cited: 3

Emelie Heintz, Ann-Britt Wiréhn, Beatrice Bourghardt Peebo, Ulf Rosenqvist and Lars-Åke Levin
  QALY weights for diabetic retinopathy: a comparison of health state valuations with HUI-3, EQ-5D, EQ-VAS, and TTO.
 
Altmetric usage: 1

  Value in Health, 2012, 15(3), 475-484.
 Web of Science® Times Cited: 3

Emelie Heintz, Ann-Britt Wiréhn, Beatrice Peebo Bourghardt, U Rosenqvist and Lars-Åke Levin
  Prevalence and healthcare costs of diabetic retinopathy: a population-based register study in Sweden
  Diabetologia, 2010, 53(10), 2147-2154.
 Web of Science® Times Cited: 16

Emelie Heintz, Thor-Henrik Brodtkorb, Nina Nelson and Lars-Åke Levin
  The long-term cost-effectiveness of fetal monitoring during labour: a comparison of cardiotocography complemented with ST analysis versus cardiotocography alone
  British Journal of Obstetrics and Gynecology, 2008, 115, 1676-1687.
 Web of Science® Times Cited: 13

Conference Articles

Emelie Heintz, Bourghardt B. Peebo, Ann-Britt Wiréhn, U. Rosenqvist and Lars-Åke Levin
  QUALITY-ADJUSTED LIFE-YEAR (QALY) WEIGHTS ASSOCIATED WITH DIFFERENT SEVERITY LEVELS OF DIABETIC RETINOPATHY in VALUE IN HEALTH, vol 13, issue 7, pp A297-A297
  VALUE IN HEALTH, 2010.


Ph.D. Theses

Emelie Heintz
  Health economic aspects of diabetic retinopathy
  2012.


  Fulltext PDF

Reports

Thor-Henrik Brodtkorb, Emelie Heintz and Almina Kalkan
  QALY som effektmått inom vården. Möjligheter och begränsningar: Kapitel 3. Metoder för värdering av QALYS
  CMT Rapport, 2012:2, 2012.


Thor-Henrik Brodtkorb, Jenny Alwin, Emelie Heintz, Kerstin Roback and Per Carlsson
  Förutsättningar för etablering av en nationell prioriteringskommitté i hälso- och sjukvården: Erfarenheter från andra länder
  CMT Rapport, 2011:2, 2011.


  Fulltext PDF

Per Carlsson, Jenny Alwin, Thor-Henrik Brodtkorb, Emelie Heintz, Jan Persson, Kerstin Roback and Gustav Tinghög
  Nationellt system för utvärdering, prioritering och införandebeslut av icke-farmakologiska sjukvårdsteknologier: en förstudie
  CMT Rapport, 2010:1, 2010.


  Fulltext PDF

Lars-Åke Levin, David Andersson, Anders Anell, Emelie Heintz, Mikael Hoffman, Andrea Schmidt and Per Carlsson
  Styrformer för effektiv läkemedelsanvändning
  CMT Rapport, 2010:2, 2010.


  Fulltext PDF

Emelie Heintz
  The cost-effectiveness of foetal monitoring with ST analysis
  CMT Rapport, 2007:8, 2008.


  Fulltext PDF

* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.